Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal

Biological Psychiatry

Volumn 71, Issue 3, 2012, Pages 214-223

  Plaza Zabala, Ainhoa ^a   Flores, África ^a   Maldonado, Rafael ^a   Berrendero, Fernando ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Hypocretin; nicotine; PVN; SB334867; TCSOX229; withdrawal

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; MECAMYLAMINE; MICROSPHERE; NICOTINE; OREXIN; OREXIN 1 RECEPTOR; PROTEIN C FOS; RHODAMINE; TCSOX 229; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN NERVE CELL; BRAIN REGION; CONTROLLED STUDY; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; IMMUNOFLUORESCENCE TEST; MALE; MOUSE; NICOTINE WITHDRAWAL; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

ANIMALS; ANTIGENS, SURFACE; BENZOXAZOLES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOQUINOLINES; MALE; MECAMYLAMINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROINJECTIONS; MOLECULAR IMAGING; NEUROANATOMICAL TRACT-TRACING TECHNIQUES; NEUROPEPTIDES; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PYRIDINES; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER; UREA;

EID: 84855427935     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2011.06.025     Document Type: Article

References (60)

1. N.L. Benowitz Pharmacology of nicotine: Addiction, smoking-induced disease, and therapeutics Annu Rev Pharmacol Toxicol 49 2009 57 71
2. S.S. Allen, T. Bade, D. Hatsukami, B. Center Craving, withdrawal, and smoking urges on days immediately prior to smoking relapse Nicotine Tob Res 10 2008 35 45
3. J.R. Hughes, D. Hatsukami Signs and symptoms of tobacco withdrawal Arch Gen Psychiatry 43 1986 289 294 (Pubitemid 16052281)
4. J.R. Hughes Effects of abstinence from tobacco: Valid symptoms and time course Nicotine Tob Res 9 2007 315 327 (Pubitemid 46404264)
5. D.H. Malin, J.R. Lake, P. Newlin-Maultsby, L.K. Roberts, J.G. Lanier, V.A. Carter Rodent model of nicotine abstinence syndrome Pharmacol Biochem Behav 43 1992 779 784
6. A. Castaé, E. Valjent, C. Ledent, M. Parmentier, R. Maldonado, O. Valverde Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence Neuropharmacology 43 2002 857 867 (Pubitemid 35221396)
7. K.J. Jackson, B.R. Martin, J.P. Changeux, M.I. Damaj Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs J Pharmacol Exp Ther 325 2008 302 312 (Pubitemid 351439184)
8. P.M. Johnson, J.A. Hollander, P.J. Kenny Decreased brain reward function during nicotine withdrawal in C57BL6 mice: Evidence from intracranial self-stimulation (ICSS) studies Pharmacol Biochem Behav 90 2008 409 415
9. F. Berrendero, P. Robledo, J.M. Trigo, E. Martín-García, R. Maldonado Neurobiological mechanisms involved in nicotine dependence and reward: Participation of the endogenous opioid system Neurosci Biobehav Rev 35 2010 220 231
10. R. Salas, R. Sturm, J. Boulter, M. De Biasi Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice J Neurosci 29 2009 3014 3018
11. L. de Lecea, T.S. Kilduff, C. Peyron, X. Gao, P.E. Foye, P.E. Danielson The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity Proc Natl Acad Sci U S A 95 1998 322 327 (Pubitemid 28103952)
12. T. Sakurai, A. Amemiya, M. Ishii, I. Matsuzaki, R.M. Chemelli, H. Tanaka Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior Cell 92 1998 573 585 (Pubitemid 28101119)
13. T. Sakurai, M. Mieda, N. Tsujino The orexin system: Roles in sleep/wake regulation Ann N Y Acad Sci 1200 2010 149 161
14. P. Bonnavion, L. de Lecea Hypocretins in the control of sleep and wakefulness Curr Neurol Neurosci Rep 10 2010 174 179
15. G. Aston-Jones, R.J. Smith, G.C. Sartor, D.E. Moorman, L. Massi, P. Tahsili-Fahadan, K.A. Richardson Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction Brain Res 1314 2010 74 90
16. W.A. Corrigall Hypocretin mechanisms in nicotine addiction: Evidence and speculation Psychopharmacology (Berl) 206 2009 23 37
17. P.J. Kenny Tobacco dependence, the insular cortex and the hypocretin connection Pharmacol Biochem Behav 97 2011 700 707
18. J.A. Hollander, Q. Lu, M.D. Cameron, T.M. Kamenecka, P.J. Kenny Insular hypocretin transmission regulates nicotine reward Proc Natl Acad Sci U S A 105 2008 19480 19485
19. M.G. LeSage, J.L. Perry, C.M. Kotz, D. Shelley, W.A. Corrigall Nicotine self-administration in the rat: Effects of hypocretin antagonists and changes in hypocretin mRNA Psychopharmacology (Berl) 209 2010 203 212
20. A. Plaza-Zabala, E. Martín-García, L. de Lecea, R. Maldonado, F. Berrendero Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior J Neurosci 30 2010 2300 2310
21. R.M. Chemelli, J.T. Willie, C.M. Sinton, J.K. Elmquist, T. Scammell, C. Lee Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation Cell 98 1999 437 451 (Pubitemid 29402482)
22. T. Mochizuki, A. Crocker, S. McCormack, M. Yanagisawa, T. Sakurai, T.E. Scammell Behavioral state instability in orexin knock-out mice J Neurosci 24 2004 6291 6300 (Pubitemid 38944219)
23. M. Narita, Y. Nagumo, S. Hashimoto, M. Narita, J. Khotib, M. Miyatake Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine J Neurosci 26 2006 398 405 (Pubitemid 43237102)
24. K.J. Kovács Measurement of immediate-early gene activation c-fos and beyond J Neuroendocrinol 20 2008 665 672 (Pubitemid 351858715)
25. A. Armario Activation of the hypothalamic-pituitary-adrenal axis by addictive drugs: Different pathways, common outcome Trends Neurosci 31 2010 318 325
26. C. Peyron, D.K. Tighe, A.N. van den Pol, L. de Lecea, H.C. Heller, J.G. Sutcliffe, T.S. Kilduff Neurons containing hypocretin (orexin) project to multiple neuronal systems J Neurosci 18 1998 9996 10015 (Pubitemid 28543775)
27. Y. Date, Y. Ueta, H. Yamashita, H. Yamaguchi, S. Matsukura, K. Kangawa Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems Proc Natl Acad Sci U S A 96 1999 748 753 (Pubitemid 29061280)
28. G.J. Hervieu, J.E. Cluderay, D.C. Harrison, J.C. Roberts, R.A. Leslie Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord Neuroscience 103 2001 777 797 (Pubitemid 32239341)
29. M. Bckberg, G. Hervieu, S. Wilson, B. Meister Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: Focus on orexin targets involved in control of food and water intake Eur J Neurosci 15 2002 315 328 (Pubitemid 35471953)
30. R.J. West, P. Hajek, M. Belcher Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking Psychol Med 19 1989 981 985 (Pubitemid 20012264)
31. X. Zhou, J. Nonnemaker, B. Sherrill, A.W. Gilsenan, F. Coste, R. West Attempts to quit smoking and relapse: Factors associated with success or failure from the ATTEMPT cohort study Addict Behav 34 2009 365 373
32. J.N. Marcus, C.J. Aschkenasi, C.E. Lee, R.M. Chemelli, C.B. Saper, M. Yanagisawa, J.K. Elmquist Differential expression of orexin receptors 1 and 2 in the rat brain J Comp Neurol 435 2001 6 25 (Pubitemid 32448719)
33. R.J. Smith, R.E. See, G. Aston-Jones Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking Eur J Neurosci 30 2009 493 503
34. J.R. Shoblock, N. Welty, L. Aluisio, I. Fraser, S.T. Motley, K. Morton Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement Psychopharmacology (Berl) 215 2011 191 203
35. R. Sharf, M. Sarhan, R.J. DiLeone Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell Biol Psychiatry 64 2008 175 183
36. D. Georgescu, V. Zachariou, M. Barrot, M. Mieda, J.T. Willie, A.J. Eisch Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal J Neurosci 23 2003 3106 3111 (Pubitemid 36531950)
37. T.L. Horvath, S. Diano, A.N. van den Pol Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: A novel circuit implicated in metabolic and endocrine regulations J Neurosci 19 1999 1072 1087 (Pubitemid 29066169)
38. C. Nez, A. Földes, M.L. Laorden, M.V. Milanes, K.J. Kovács Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal J Neurochem 101 2007 1060 1071 (Pubitemid 46683869)
39. T.P. Sheehan, R.A. Chambers, D.S. Russell Regulation of affect by the lateral septum: Implications for neuropsychiatry Brain Res Brain Res Rev 46 2004 71 117 (Pubitemid 39036164)
40. G.M. Singewald, A. Rjabokon, N. Singewald, K. Ebner The modulatory role of the lateral septum on neuroendocrine and behavioral stress responses Neuropsychopharmacology 36 2011 793 804
41. A.M. Ouagazzal, P.J. Kenny, S.E. File Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety Eur J Neurosci 11 1999 3957 3962 (Pubitemid 29537575)
42. S. Cheeta, P.J. Kenny, S.E. File The role of 5-HT1A receptors in mediating the anxiogenic effects of nicotine following lateral septal administration Eur J Neurosci 12 2000 3797 3802
43. M. Jalabert, G. Aston-Jones, E. Herzog, O. Manzoni, F. Georges Role of the bed nucleus of the stria terminalis in the control of ventral tegmental area dopamine neurons Prog Neuropsychopharmacol Biol Psychiatry 33 2009 1336 1346
44. E. Carboni, A. Silvagni, M.T. Rolando, G. Di Chiara Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs J Neurosci 20 2000 RC102
45. S. Jonkman, A. Markou Blockade of nicotinic acetylcholine or dopamine D1-like receptors in the central nucleus of the amygdala or the bed nucleus of the stria terminalis does not precipitate nicotine withdrawal in nicotine-dependent rats Neurosci Lett 400 2006 140 145
46. C.A. Marcinkiewcz, M.M. Prado, S.K. Isaac, A. Marshall, D. Rylkova, A.W. Bruijnzeel Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats Neuropsycopharmacology 34 2009 1743 1752
47. G. Koob A role for brain stress systems in addiction Neuron 59 2008 11 34 (Pubitemid 351905857)
48. M.L. Laorden, C. Nez, P. Almela, M.V. Milanés Morphine withdrawal-induced c-fos expression in the hypothalamic paraventricular nucleus is dependent on the activation of catecholaminergic neurones J Neurochem 83 2002 132 140
49. F. Papaleo, S. Ghozland, M. Ingallinesi, A.J. Roberts, G.F. Koob, A. Contarino Disruption of the CRF2 receptor pathway decreases the somatic expression of opiate withdrawal Neuropsychopharmacology 33 2008 2878 2887
50. J. Navarro-Zaragoza, C. Nez, J. Ruiz-Medina, M.L. Laorden, O. Valverde, M.V. Milanés CRF2 mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats Br J Pharmacol 162 2011 851 862
51. P.A. Iredale, J.D. Alvaro, Y. Lee, R. Terwilliger, Y.L. Chen, R.S. Duman Role of corticotropin-releasing factor receptor-1 in opiate withdrawal J Neurochem 74 2000 199 208 (Pubitemid 30012770)
52. F. Papaleo, P. Kitchener, A. Contarino Disruption of the CFR/CRF1 receptor stress system exacerbates the somatic signs of opiate withdrawal Neuron 53 2007 577 589 (Pubitemid 46216753)
53. J. Navarro-Zaragoza, C. Nez, M.L. Laorden, M.V. Milanés Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal Mol Pharmacol 77 2010 864 873
54. R. Winsky-Sommerer, B. Boutrel, L. de Lecea The corticotrophin-releasing factor/hypocretin circuitry Mol Neurobiol 32 2005 285 294
55. T. Shirasaka, S. Miyahara, T. Kunitake, Q.H. Jin, K. Kato, M. Takasaki, H. Kannan Orexin depolarizes rat hypothalamic paraventricular nucleus neurons Am J Physiol Regul Integr Comp Physiol 281 2001 R1114 R1118
56. W.K. Samson, M.M. Taylor, M. Follwell, A.V. Ferguson Orexin actions in hypothalamic paraventricular nucleus: Physiological consequences and cellular correlates Regul Pept 104 2002 97 103 (Pubitemid 34119379)
57. M.J. Follwell, A.V. Ferguson Cellular mechanisms of orexin actions on paraventricular nucleus neurones in rat hypothalamus J Physiol 545 2002 855 867 (Pubitemid 36024425)
58. Y. Qi, M.R. Namavar, J. Iqbal, B.J. Oldfield, I.J. Clarke Characterization of the projections to the hypothalamic paraventricular and periventricular nuclei in the female sheep brain, using retrograde tracing and immunohistochemistry Neuroendocrinology 90 2009 31 53
59. C. Boudaba, L.A. Schrader, J.G. Tasker Physiological evidence for local excitatory synaptic circuits in the rat hypothalamus J Neurophysiol 77 1997 3396 3400 (Pubitemid 27290904)
60. G. Paxinos, K.B.J. Franklin The Mouse Brain in Stereotaxic Coordinates 1997 Academic Press San Diego